Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

Indole endothelin antagonists prepared at Pfizer

Jan. 28, 1998

AtheroGenics initiates phase I testing for new cardiovascular drug

Jan. 27, 1998

New ET antagonists from Merck KGaA bearing a benzothiadiazole functionality

Jan. 27, 1998

U.K. launch for Posicor

Jan. 27, 1998

ACAT-inhibitory anilides from Kowa are particularly useful for atherosclerosis

Jan. 27, 1998

Takeda discloses compounds that upregulate LDL receptors

Jan. 27, 1998

Adenosine metabolism inhibitor research at Cypros supported by grant

Jan. 26, 1998

Atherosclerosis program at Genome Therapeutics expanded

Jan. 26, 1998

Two NDAs up for review this week by Cardiovascular and Renal Drugs Advisory Committee

Jan. 26, 1998

T Cell Sciences awarded SBIR grant for atherosclerosis vaccine

Jan. 23, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...